Efficacy comparison of adjuvants in PcrV vaccine againstPseudomonas aeruginosapneumonia-Reference-Cited by-同舟云学术

Efficacy comparison of adjuvants in PcrV vaccine againstPseudomonas aeruginosapneumonia

Published:2017-02 Issue:2 Volume:61 Page:64-74
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:Microbiol Immunol

Author:

Hamaoka Saeko¹,Naito Yoshifumi¹,Katoh Hideya¹,Shimizu Masaru¹,Kinoshita Mao¹,Akiyama Koichi¹,Kainuma Atsushi¹,Moriyama Kiyoshi²,Ishii Ken J.³⁴,Sawa Teiji¹

Affiliation:

1. Department of Anesthesiology; Kyoto Prefectural University of Medicine; Kyoto 602-8566 Japan

2. Department of Anesthesiology; School of Medicine; Kyorin University; Mitaka 181-8611 Japan

3. Laboratory of Adjuvant Innovation, National Institutes of Biomedical Innovation; Health and Nutrition; Ibaraki Osaka 567-0085 Japan

4. Laboratory of Vaccine Science, Immunology Frontier Research Center, World Premier International Research Center; Osaka University; Suita Osaka 565-0871 Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1348-0421.12467/fullpdf

Reference59 articles.

1. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010;Sievert;Infect Control Hosp Epidemiol,2013

2. Pneumonia due to Pseudomonas aeruginosa: Part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy;Sun;Chest,2011

3. International study of the prevalence and outcomes of infection in intensive care units;Vincent;JAMA,2009